These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 33397692

  • 1. Long-Term Survival of Virulent Tularemia Pathogens outside a Host in Conditions That Mimic Natural Aquatic Environments.
    Golovliov I, Bäckman S, Granberg M, Salomonsson E, Lundmark E, Näslund J, Busch JD, Birdsell D, Sahl JW, Wagner DM, Johansson A, Forsman M, Thelaus J.
    Appl Environ Microbiol; 2021 Feb 26; 87(6):. PubMed ID: 33397692
    [Abstract] [Full Text] [Related]

  • 2. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.
    Jia Q, Horwitz MA.
    Front Cell Infect Microbiol; 2018 Feb 26; 8():154. PubMed ID: 29868510
    [Abstract] [Full Text] [Related]

  • 3. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W.
    PLoS One; 2013 Feb 26; 8(11):e78671. PubMed ID: 24236032
    [Abstract] [Full Text] [Related]

  • 4. Impact of Francisella tularensis pilin homologs on pilus formation and virulence.
    Ark NM, Mann BJ.
    Microb Pathog; 2011 Sep 26; 51(3):110-20. PubMed ID: 21605655
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Virulence difference between the prototypic Schu S4 strain (A1a) and Francisella tularensis A1a, A1b, A2 and type B strains in a murine model of infection.
    Molins CR, Delorey MJ, Yockey BM, Young JW, Belisle JT, Schriefer ME, Petersen JM.
    BMC Infect Dis; 2014 Feb 06; 14():67. PubMed ID: 24502661
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to Francisella tularensis.
    Mohammadi N, Lindgren H, Yamamoto M, Martin A, Henry T, Sjöstedt A.
    Front Cell Infect Microbiol; 2021 Feb 06; 11():784101. PubMed ID: 35004352
    [Abstract] [Full Text] [Related]

  • 11. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar 06; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
    Pechous RD, McCarthy TR, Mohapatra NP, Soni S, Penoske RM, Salzman NH, Frank DW, Gunn JS, Zahrt TC.
    PLoS One; 2008 Jun 25; 3(6):e2487. PubMed ID: 18575611
    [Abstract] [Full Text] [Related]

  • 14. Contributions of TolC Orthologs to Francisella tularensis Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence.
    Kopping EJ, Doyle CR, Sampath V, Thanassi DG.
    Infect Immun; 2019 Apr 25; 87(4):. PubMed ID: 30670554
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.
    Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH.
    Infect Immun; 2008 Dec 25; 76(12):5843-52. PubMed ID: 18852251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
    Santiago AE, Mann BJ, Qin A, Cunningham AL, Cole LE, Grassel C, Vogel SN, Levine MM, Barry EM.
    Pathog Dis; 2015 Aug 25; 73(6):ftv036. PubMed ID: 25986219
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.